These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

534 related articles for article (PubMed ID: 34505766)

  • 1. Delivery of Oligonucleotide Therapeutics: Chemical Modifications, Lipid Nanoparticles, and Extracellular Vesicles.
    Bost JP; Barriga H; Holme MN; Gallud A; Maugeri M; Gupta D; Lehto T; Valadi H; Esbjörner EK; Stevens MM; El-Andaloussi S
    ACS Nano; 2021 Sep; 15(9):13993-14021. PubMed ID: 34505766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent developments in oligonucleotide conjugation.
    Singh Y; Murat P; Defrancq E
    Chem Soc Rev; 2010 Jun; 39(6):2054-70. PubMed ID: 20393645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular Trafficking and Endosomal Release of Oligonucleotides: What We Know and What We Don't.
    Juliano RL
    Nucleic Acid Ther; 2018 Jun; 28(3):166-177. PubMed ID: 29708838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery.
    Cheng X; Lee RJ
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):129-137. PubMed ID: 26900977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Oligonucleotides: An Outlook on Chemical Strategies to Improve Endosomal Trafficking.
    Mangla P; Vicentini Q; Biscans A
    Cells; 2023 Sep; 12(18):. PubMed ID: 37759475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endosomal escape of nucleic acids from extracellular vesicles mediates functional therapeutic delivery.
    Pham TT; Chen H; Nguyen PHD; Jayasinghe MK; Le AH; Le MT
    Pharmacol Res; 2023 Feb; 188():106665. PubMed ID: 36657503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unraveling the Mechanisms of Peptide-Mediated Delivery of Nucleic Acids Using Electron Microscopy.
    Margus H; Juks C; Pooga M
    Methods Mol Biol; 2015; 1324():149-62. PubMed ID: 26202268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyaluronan-based delivery of therapeutic oligonucleotides for treatment of human diseases.
    Ossipov DA
    Expert Opin Drug Deliv; 2019 Jun; 16(6):621-637. PubMed ID: 31072142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of oligonucleotides with lipid nanoparticles.
    Wang Y; Miao L; Satterlee A; Huang L
    Adv Drug Deliv Rev; 2015 Jun; 87():68-80. PubMed ID: 25733311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current Challenges in Delivery and Cytosolic Translocation of Therapeutic RNAs.
    Johannes L; Lucchino M
    Nucleic Acid Ther; 2018 Jun; 28(3):178-193. PubMed ID: 29883296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel non-endocytic delivery of antisense oligonucleotides.
    Dokka S; Rojanasakul Y
    Adv Drug Deliv Rev; 2000 Oct; 44(1):35-49. PubMed ID: 11035196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides.
    Remaut K; Lucas B; Braeckmans K; Demeester J; De Smedt SC
    J Control Release; 2007 Feb; 117(2):256-66. PubMed ID: 17188777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulating intracellular pathways to improve non-viral delivery of RNA therapeutics.
    Van de Vyver T; De Smedt SC; Raemdonck K
    Adv Drug Deliv Rev; 2022 Feb; 181():114041. PubMed ID: 34763002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel endosomolytic compounds enable highly potent delivery of antisense oligonucleotides.
    Bost JP; Ojansivu M; Munson MJ; Wesén E; Gallud A; Gupta D; Gustafsson O; Saher O; Rädler J; Higgins SG; Lehto T; Holme MN; Dahlén A; Engkvist O; Strömstedt PE; Andersson S; Edvard Smith CI; Stevens MM; Esbjörner EK; Collén A; El Andaloussi S
    Commun Biol; 2022 Mar; 5(1):185. PubMed ID: 35233031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence-defined polymers for the delivery of oligonucleotides.
    Lehto T; Wagner E
    Nanomedicine (Lond); 2014 Dec; 9(18):2843-59. PubMed ID: 25535686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oligonucleotide delivery: a cellular prospective.
    Liang E; Ajmani PS; Hughes JA
    Pharmazie; 1999 Aug; 54(8):559-66. PubMed ID: 10483609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of phosphodiester oligonucleotides: can DOTAP/DOPE liposomes do the trick?
    Remaut K; Lucas B; Braeckmans K; Sanders NN; Demeester J; De Smedt SC
    Biochemistry; 2006 Feb; 45(6):1755-64. PubMed ID: 16460022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical Manipulation of the Endosome Trafficking Machinery: Implications for Oligonucleotide Delivery.
    Juliano RL
    Biomedicines; 2021 May; 9(5):. PubMed ID: 34063104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress on RNA-based therapeutics for genetic diseases.
    Luo T; Huo C; Zhou T; Xie S
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2023 Aug; 52(4):406-416. PubMed ID: 37643975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the Therapeutic Potential of Extracellular Vesicles Using Peptide Technology.
    Martin Perez C; Conceição M; Raz R; Wood MJA; Roberts TC
    Methods Mol Biol; 2022; 2383():119-141. PubMed ID: 34766286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.